This inventor holds 3 USPTO granted patents. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 1997-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2000
Title: Jurgen Hubert Nagel: Innovator in Medicinal Aerosol Solutions
Introduction
Jurgen Hubert Nagel is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of medicinal aerosol solutions, holding a total of 3 patents. His work focuses on developing stabilized formulations that enhance the efficacy and stability of medicinal aerosols.
Latest Patents
Nagel's latest patents include innovative formulations for stabilized medicinal aerosol solutions. These formulations comprise medicaments that are prone to degradation or decomposition when interacting with solvents or water. His patents describe the use of an HFC propellant, a cosolvent, and an acid to maintain the stability of these medicaments. Specifically, he has developed formulations that include ipratropium bromide or fenoterol, ethyl alcohol, and various fluorinated propellants. The inclusion of either inorganic or organic acids in these formulations is crucial, as they are present in amounts sufficient to reduce the degradation of the medicaments to acceptable levels.
Career Highlights
Jurgen Hubert Nagel is currently associated with Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to innovate in the field of medicinal aerosols. His expertise and dedication to research have positioned him as a key figure in the development of effective aerosol therapies.
Collaborations
Throughout his career, Nagel has collaborated with esteemed colleagues such as Paul Donald Jager and Mark James Kontny. These collaborations have further enriched his research and contributed to the advancement of aerosol technology.
Conclusion
Jurgen Hubert Nagel's work in the field of medicinal aerosol solutions exemplifies innovation and dedication to improving healthcare. His patents reflect a commitment to enhancing the stability and efficacy of medicinal formulations, making a significant impact in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
